Janssen has a long-standing history in making a meaningful difference in global public health, dating back to Dr. Paul Janssen’s pioneering work in mental health and pain medications, as well as the development of more than 80 medicines, four of which are included on the World Health Organization’s List of Essential Medicines. Inspired by his legacy, we aim to help more people in more places have access to our medicines and to sustainable, effective healthcare solutions.
Across Janssen and as part of Johnson & Johnson, we have a number of programs that work to strengthen the health of communities, improve maternal and child health, and prevent the spread of infectious and preventable diseases through vaccination. Our Janssen Global Public Health group strives to address the world’s greatest unmet public health needs by:
- ensuring we have research efforts focused on neglected diseases and medical needs that disproportionally impact public health settings
- creating new models and facilitating sustainable and affordable access to our medicines in developing markets
- collaborating with the global healthcare community to develop innovative solutions that improve health outcomes for individuals, families and communities
Ultimately, we strive to reimagine how our business can deliver on the promise of our vaccines, diagnostics, medicines and services to address unmet public health needs across the world. We do this because we want to make a meaningful difference in global public health.